Medicine repurposing – Why start from scratch?
As more products are being registered on the Australian Register of Therapeutic Goods (ARTG) for therapeutic claims beyond their original purpose, there is an increasing potential for medicine…
6 things you need to know to launch a cosmetic in Australia
PBAC Pre-Submission Meetings – What to expect and are they of value?
Stage 1 PBS Process Improvements commenced 1 July 2019 and included the introduction of changes to pre-submission meetings to provide additional guidance and support for complex submissions….
The importance of treatment effects in economic evaluation
The effectiveness of one intervention compared to another, also known as the treatment effect, is frequently a key consideration when assessing the cost-effectiveness of alternative therapeutic interventions for economic…
Events & Webinars, Latest News,
Commercial Eyes receives marketing award for product launch campaign
Congratulations to Associate Director, Dianne Gill and our Medical Communications & Patient Engagement team for receiving a Diamond Award from Consumer Healthcare Products…
International Women’s Day: Celebrating Women at Commercial Eyes
From the beginning, the company has been a workplace that has embraced and rewarded women for the great work that they…
Medical Devices: Reclassification framework of certain devices
The TGA has commenced the implementation of revised medical device…
Commercial Eyes Proudly Celebrates 20th Birthday!
From humble beginnings and with big aspirations, on this day 20 years ago Commercial Eyes was founded and over the last two decades has grown to be the foremost therapeutics…
How will the new Strategic Agreements impact your business?
Medicines Australia and Generic and Biosimilars Association have secured new 5 year agreements with the Commonwealth for timely access to and reimbursement of medicines and policy settings that recognise the…
New TGA framework to redefine personalised medical devices
This post will cover the recent changes brought to regulation of personalised medical devices, under a new TGA…
Commercial Eyes acquires Open Sesame Consulting
We are excited to announce the acquisition of Open Sesame Consulting by Commercial…
A thriving business in dormant times
We are in the business of assisting clients bring their medicines, medical devices, and diagnostics to the Australian market….
Happy Birthday Commercial Eyes!
In a consulting company, there is no ‘product’ without the people. Without the people, Commercial Eyes Pty Ltd would simply be a ‘legal entity’, without any real function, personality or…
TGO 91 and TGO 92 – are your labels ready?
Sponsors should check that their medicine labels comply with the relevant…
Does social prescribing impact broader health outcomes?
Whilst the term may be relatively new to mainstream practice in Australia, the idea is…
Coronavirus (COVID-19): Information on medicines and medical devices supply in Australia
Access the latest information about the special regulatory requirements for the supply of medicines and devices (including exemptions) in Australia during the…
Thanks for giving a country kid a go
A big thank you, John Kennedy, for giving a kid from the country a…
Improved Consumer Medicine Information template
The TGA have now released implementation dates for the updated Consumer Medicine Information (CMI)…
Pandemic disruption and a new MA code update; what for patient programs in this new era?
COVID-19 has taught us that in times of uncertainty, people seek information and…
Hand sanitiser – What do you need to know to supply in Australia?
The COVID-19 pandemic has seen the TGA rapidly changing the regulatory landscape for in-demand products that can help reduce the spread of the virus. Given all the changes taking place,…
(NOT) BUSINESS AS USUAL
At Commercial Eyes, we focus our efforts on supporting clients in the regulated therapeutics industry get their products to the patients who need them, when they need…